---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-098505"
form_type: "8-K"
ticker: "REVB"
cik: "0001810560"
company_name: "REVELATION BIOSCIENCES, INC."
filed_at: "2024-08-19T23:59:59+00:00"
generated_at: "2026-05-31T08:42:25.872139+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Revelation Biosciences warns of delisting risk; stockholders' equity only $1.14M vs $2.5M minimum

## Summary
- Received Nasdaq letter on Aug 14, 2024, citing insufficient stockholders' equity of $1,140,421 vs required $2.5M.
- Also failed alternative listing standards (market value of listed securities ≥$35M or net income from continuing ops $500K).
- Company has 45 days to submit a plan to regain compliance; Nasdaq may grant up to 180-day extension.
- No immediate effect on trading; common stock and warrants continue trading under REVB and REVBW.
- Company intends to take reasonable measures but no assurance of extension or regaining compliance.

## SEC filing metadata
- accession: 0000950170-24-098505
- form_type: 8-K
- ticker: REVB
- cik: 0001810560
- company_name: REVELATION BIOSCIENCES, INC.
- filed_at: 2024-08-19T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810560/000095017024098505/0000950170-24-098505-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810560/000095017024098505/revb-20240814.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-098505
- JSON: https://secwatch.observer/filing/0000950170-24-098505.json
- Plain text: https://secwatch.observer/filing/0000950170-24-098505.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.